An affiliate of Smith & Nephew will acquire ownership of all product and intellectual property assets related to BST-CarGel
Piramal Enterprises has announced the sale of BST-CarGel from Piramal Healthcare (Canada), based in Montreal, Canada to Smith & Nephew, the global medical technology business.
BST-CarGel is a first-line cartilage repair product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears. Through this transaction, an affiliate of Smith & Nephew will acquire ownership of all product and intellectual property assets related to BST-CarGel.
The transaction does not have a material impact on the financials of PEL.
EH News Bureau
- Advertisement -
Comments are closed.